Viewing Study NCT06621459

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:06 PM
Ignite Modification Date: 2026-01-17 @ 11:14 PM
Study NCT ID: NCT06621459
Status: RECRUITING
Last Update Posted: 2024-10-01
First Post: 2024-09-27
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Retrospective Observational Study of the Safety and Toxicity Management of Abemaciclib in Combination with Adjuvant Hormone Therapy in Patients with RH+ ,HER2-nonoveramplified Breast Cancer, Real-life Data (MONARCHE29)
Sponsor: University Hospital, Brest
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Brest Cancer View
None Abemaciclib View
None Adjuvant Therapy View
None Antineoplastic Combined Chemotherapy Protocols View
None Breast Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Abemaciclib View
None Adjuvant Therapy View
None Antineoplastic Combined Chemotherapy Protocols View
None Breast Cancer View
None Real-life View
None Real Word Data View